| Literature DB >> 27317854 |
Min Jea Shin1, Dae Won Kim2, Hyo Sang Jo1, Su Bin Cho1, Jung Hwan Park1, Chi Hern Lee1, Eun Ji Yeo1, Yeon Joo Choi1, Ji An Kim3, Jung Soon Hwang3, Eun Jeong Sohn1, Ji-Heon Jeong4, Duk-Soo Kim4, Hyeok Yil Kwon5, Yong-Jun Cho6, Keunwook Lee1, Kyu Hyung Han1, Jinseu Park1, Won Sik Eum7, Soo Young Choi8.
Abstract
Proline rich Akt substrate (PRAS40) is a component of mammalian target of rapamycin complex 1 (mTORC1) and is known to play an important role against reactive oxygen species-induced cell death. However, the precise function of PRAS40 in ischemia remains unclear. Thus, we investigated whether Tat-PRAS40, a cell-permeable fusion protein, has a protective function against oxidative stress-induced hippocampal neuronal (HT-22) cell death in an animal model of ischemia. We showed that Tat-PRAS40 transduced into HT-22 cells, and significantly protected against cell death by reducing the levels of H2O2 and derived reactive species, and DNA fragmentation as well as via the regulation of Bcl-2, Bax, and caspase 3 expression levels in H2O2 treated cells. Also, we showed that transduced Tat-PARS40 protein markedly increased phosphorylated RRAS40 expression levels and 14-3-3σ complex via the Akt signaling pathway. In an animal ischemia model, Tat-PRAS40 effectively transduced into the hippocampus in animal brain and significantly protected against neuronal cell death in the CA1 region. We showed that Tat-PRAS40 protein effectively transduced into hippocampal neuronal cells and markedly protected against neuronal cell damage. Therefore, we suggest that Tat-PRAS40 protein may be used as a therapeutic protein for ischemia and oxidative stress-induced brain disorders.Entities:
Keywords: Brain ischemia; Cell death; Oxidative stress; Protein therapy; Tat-PRAS40
Mesh:
Substances:
Year: 2016 PMID: 27317854 DOI: 10.1016/j.freeradbiomed.2016.06.009
Source DB: PubMed Journal: Free Radic Biol Med ISSN: 0891-5849 Impact factor: 7.376